Home
BMY
BMY News

Latest Bristol-Myers Squibb Company (BMY) News on January 20, 2025

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

Insider Monkey

2 days ago

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TipRanks

2 days ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts

Zacks

3 days ago

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts

MT Newswires

3 days ago

Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

The Wall Street Journal

3 days ago

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Yahoo Finance

3 days ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

Zacks

6 days ago

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

MT Newswires

7 days ago

Bristol-Myers Squibb Company Exercises Exclusive License Option for ArsenalBio's AB-4000 Series

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

GlobeNewswire

7 days ago

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Yahoo Finance Video

10 days ago

AI, vaccine distrust, & the future of healthcare: Novartis CEO

MT Newswires

10 days ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $52 From $53, Maintains Neutral Rating

Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

11 days ago

Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

Benzinga

11 days ago

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

Zacks

11 days ago

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

This Unpopular Dividend Stock Is a Buy

Motley Fool

11 days ago

This Unpopular Dividend Stock Is a Buy

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

Zacks

12 days ago

Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?

MT Newswires

12 days ago

Truist Raises Price Target on Bristol-Myers Squibb to $65 From $62, Keeps Buy Rating

Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?

Insider Monkey

13 days ago

Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?

Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet

Simply Wall St.

13 days ago

Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

Motley Fool

16 days ago

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

Zacks

17 days ago

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

Business Wire

17 days ago

Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

MT Newswires

17 days ago

Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025

Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years

Simply Wall St.

18 days ago

Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years

FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024

BioPharma Dive

18 days ago

FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024

Corcept Submits Application for Another Cushing's Syndrome Drug

Zacks

20 days ago

Corcept Submits Application for Another Cushing's Syndrome Drug

Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?

Insider Monkey

20 days ago

Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?

Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

Zacks

20 days ago

Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?

2 High-Yield Dividend Stocks to Buy Early in 2025

Motley Fool

20 days ago

2 High-Yield Dividend Stocks to Buy Early in 2025

Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?

Insider Monkey

21 days ago

Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?

FDA approves BMS’ Opdivo Qvantig for solid tumour indications

Pharmaceutical Technology

21 days ago

FDA approves BMS’ Opdivo Qvantig for solid tumour indications

Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year

Simply Wall St.

22 days ago

Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year

Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know

Zacks

24 days ago

Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know

U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2

Business Wire

24 days ago

U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2

MT Newswires

24 days ago

Bristol-Myers Squibb's Opdivo Qvantig Gets US FDA Approval

FDA Approval of Injectable Opdivo: Bristol Myers Squibb Fights Off Patent Cliff Concerns

GuruFocus.com

24 days ago

FDA Approval of Injectable Opdivo: Bristol Myers Squibb Fights Off Patent Cliff Concerns

FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo

Reuters

24 days ago

FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?

Zacks

25 days ago

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?

Argus Research

25 days ago

Technical Assessment: Bullish in the Intermediate-Term

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer

Zacks

a month ago

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer

BMS sees success in Phase III Sotyktu psoriatic arthritis trials

Clinical Trials Arena

a month ago

BMS sees success in Phase III Sotyktu psoriatic arthritis trials

MT Newswires

a month ago

Bristol-Myers Squibb Says Phase 3 Trials of Sotyktu in Psoriatic Arthritis Meets Endpoints

MT Newswires

a month ago

Bristol-Myers Squibb Secures EU Approval for Opdivo, Yervoy Combination in Colorectal Cancer

Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis

Business Wire

a month ago

Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

Business Wire

a month ago

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%

Simply Wall St.

a month ago

Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%

Want Decades of Passive Income? 3 Stocks to Buy Right Now

Motley Fool

a month ago

Want Decades of Passive Income? 3 Stocks to Buy Right Now

Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘This Stock Has Been Hot Since The Summer’

Insider Monkey

a month ago

Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘This Stock Has Been Hot Since The Summer’

Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today

Zacks

a month ago

Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today

Bristol Myers Squibb Stock Earns 83 RS Rating

Investor's Business Daily

a month ago

Bristol Myers Squibb Stock Earns 83 RS Rating

Jim Cramer on Bristol-Myers Squibb (BMY): Why Schizophrenia Drug Cobenfy Could Change the Game

Insider Monkey

a month ago

Jim Cramer on Bristol-Myers Squibb (BMY): Why Schizophrenia Drug Cobenfy Could Change the Game

MT Newswires

a month ago

Bristol-Myers Squibb Signs Exclusive License Deal With BioArctic for Antibody Program

3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income

Motley Fool

a month ago

3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income

Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025

Business Wire

a month ago

Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

Motley Fool

a month ago

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

Motley Fool

a month ago

These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

Is Bristol-Myers Squibb Company (BMY) the Best Cash-Rich Dividend Stock to Invest In Now?

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Cash-Rich Dividend Stock to Invest In Now?

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Is Bristol-Myers Squibb Company (BMY) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Bristol Myers upgraded to Buy at Jefferies on new launch momentum, pipeline

TipRanks

a month ago

Bristol Myers upgraded to Buy at Jefferies on new launch momentum, pipeline

Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases

Zacks

a month ago

Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases

Investing.com

a month ago

Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy

BMY vs. VRTX: Which Stock Is the Better Value Option?

Zacks

a month ago

BMY vs. VRTX: Which Stock Is the Better Value Option?

MT Newswires

a month ago

Jefferies Upgrades Bristol-Myers Squibb to Buy From Hold, Adjusts Price Target to $70 From $63

Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62

Simply Wall St.

a month ago

Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62

Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know

Zacks

a month ago

Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know

Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific

Zacks

a month ago

Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific

MT Newswires

a month ago

Bristol-Myers Squibb Files Mixed Shelf

Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now

Insider Monkey

a month ago

Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now

CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal

Zacks

a month ago

CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal

Bristol Myers Squibb Announces Dividend Increase

Business Wire

a month ago

Bristol Myers Squibb Announces Dividend Increase

Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell?

Zacks

a month ago

Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell?

Bristol Myers (BMY) Upgraded to Buy: Here's Why

Zacks

a month ago

Bristol Myers (BMY) Upgraded to Buy: Here's Why

Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?

Zacks

a month ago

Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?

Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year?

MT Newswires

a month ago

Berenberg Raises Price Target on Bristol-Myers Squibb to $60 From $55, Keeps Hold Rating

Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline

Business Wire

a month ago

Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline

Dividend Stocks Are Primed for a Comeback in 2025

The Wall Street Journal

a month ago

Dividend Stocks Are Primed for a Comeback in 2025

Argus Research

a month ago

Technical Assessment: Bullish in the Intermediate-Term

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

Zacks

2 months ago

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

Argus Research

2 months ago

Analyst Report: Bristol-Myers Squibb Co.

Argus Research

2 months ago

Market Update: BMY, CMG

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Bristol-Myers Squibb Company (BMY): Close to Becoming a Dividend Aristocrat

Insider Monkey

2 months ago

Bristol-Myers Squibb Company (BMY): Close to Becoming a Dividend Aristocrat

Morningstar Research

2 months ago

Analyst Report: Bristol-Myers Squibb Company

Is Bristol-Myers Squibb Stock a Millionaire Maker?

Motley Fool

2 months ago

Is Bristol-Myers Squibb Stock a Millionaire Maker?

3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever

Motley Fool

2 months ago

3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever

Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference

Business Wire

2 months ago

Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference

MT Newswires

2 months ago

Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating

Bristol-Myers Squibb (NYSE:BMY) increases 4.7% this week, taking one-year gains to 24%

Simply Wall St.

2 months ago

Bristol-Myers Squibb (NYSE:BMY) increases 4.7% this week, taking one-year gains to 24%

Where Will Bristol Myers Squibb Be in 5 Years?

Motley Fool

2 months ago

Where Will Bristol Myers Squibb Be in 5 Years?

AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback

Investor's Business Daily

2 months ago

AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback

Is Bristol Myers Squibb Stock a Buy?

Motley Fool

2 months ago

Is Bristol Myers Squibb Stock a Buy?

Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks

Motley Fool

2 months ago

Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms

Business Wire

2 months ago

Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

Benzinga

2 months ago

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

MT Newswires

2 months ago

Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $60 From $52, Maintains Equalweight

Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

2 months ago

Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

Pharmaceutical Technology

2 months ago

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

Share on Social Networks: